0001501989-15-000001.txt : 20150106 0001501989-15-000001.hdr.sgml : 20150106 20150106133840 ACCESSION NUMBER: 0001501989-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150106 DATE AS OF CHANGE: 20150106 EFFECTIVENESS DATE: 20150106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-231506 FILM NUMBER: 15509183 BUSINESS ADDRESS: STREET 1: 650 GATEWAY BLVD. STREET 2: SUITE 125 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 650 GATEWAY BLVD. STREET 2: SUITE 125 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001501989 CytomX Therapeutics, Inc. 343 Oyster Point Blvd. SUITE 100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650.515.3185 DELAWARE None None Corporation true 2010 Sean McCarthy 343 Oyster Point Blvd. Suite 100 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Frederick W. Gluck 343 Oyster Point Blvd. Suite 100 South San Francisco CA CALIFORNIA 94080 Director Hoyoung Huh 343 Oyster Point Blvd. Suite 100 South San Francisco CA CALIFORNIA 94080 Director Neil Exter 343 Oyster Point Blvd. Suite 100 South San Francisco CA CALIFORNIA 94080 Director Tim Shannon 343 Oyster Point Blvd. Suite 100 South San Francisco CA CALIFORNIA 94080 Director Elaine V. Jones 343 Oyster Point Blvd. Suite 100 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2014-12-22 false true false 0 29999999 16499999 13500000 An additional $3,499,999 is committed. false 4 0 0 0 false CytomX Therapeutics, Inc. /s/ Sean McCarthy Sean McCarthy CEO 2015-01-05